Loading...
Acute myeloid leukemia: current progress and future directions
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML) is occurring rapidly. Since 2017, nine agents have been approved for various indications in AML. These included several targeted therapies like venetoclax, FLT3 inhibitors, IDH inhibitors, and others. The manage...
Na minha lista:
| Udgivet i: | Blood Cancer J |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7900255/ https://ncbi.nlm.nih.gov/pubmed/33619261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00425-3 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|